Nasdaq
$6.76▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $236.6MShares out 35.0M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
4- 9.18Pre-market26.09.18 22:256-KKey event#●●●
Magnitude International Ltd
Magnitude International regained compliance with Nasdaq Listing Rule 5250(c)(1) after filing its annual report on Form 20-F on September 17, 2026. However, the separate Nasdaq delisting review initiated on August 3, 2026, under Rule IM-5101-4 remains ongoing and unresolved.…more
$6.76+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.17Pre-market26.09.17 21:2420-FEarnings
Magnitude International Ltd
Magnitude International Ltd, incorporated in the Cayman Islands on October 25, 2024, has filed its annual report on Form 20-F for the fiscal year ended April 30, 2026. The company has an authorized share capital of US$500,000, divided into 20,000,000,000 ordinary shares with a par value of US$0.000025 each.…more
$6.76+0.00%vs prev closeView filingShare - 8.31Pre-market26.08.31 20:34NT 20-FEarnings
Magnitude International Ltd
Magnitude International Ltd has announced a delay in filing its Form 20-F for the fiscal year ended April 30, 2026, due to the need for additional time to finalize financial statements and complete the audit by WWC, P.C. The company intends to submit the annual report within the 15-day extension period permitted under SEC rules.…more
$6.76+0.00%vs prev closeView filingShare
3 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.18Pre-market26.09.18 22:25Bullish#●●●
Magnitude International Receives Additional Nasdaq Delisting Notice
Magnitude International has received an additional delisting notice from Nasdaq due to the delayed filing of its annual report. This adds to existing concerns regarding potential misconduct, heightening risks for investors.…more
$6.76+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 8.31Overnight26.08.31 15:47
●●●●●●●● ●●●●● ●●●●●●
Short seller BMF Capital argues that SELLAS Life Sciences is dangerously overvalued ahead of its Phase 3 trial results. The firm warns that the stock could face a 74% downside if the clinical trial fails to meet expectations.…more
$6.76+0.00%vs prev closeShareBenzinga - 8.5Pre-market26.08.05 22:00
●●●●●●●● ●●●●● ●●●●●●
매그니튜드 인터내셔널이 나스닥으로부터 상장폐지 결정 통보를 받았으며, 회사는 이에 대해 청문회를 요청할 계획입니다. 현재 거래 정지 상태가 유지되고 있어 투자자들의 각별한 주의가 요구됩니다.…more
$6.76+0.00%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report